Navigation Links
Biotel Announces Fourth Quarter and Year End Results

MINNEAPOLIS, Sept. 30 /PRNewswire-FirstCall/ -- Biotel Inc. (OTC Bulletin Board: BTEL) announced results for the fiscal year ended June 30, 2009, with net earnings of $944,000, or $0.33 per diluted share, on revenues of $12,640,000. This compares to net earnings of $666,000, or $0.23 per diluted share on revenues of $11,495,000 in fiscal year 2008. For its fourth quarter, the Company reported net earnings of $174,000 or $0.06 per diluted share, on revenues of $3,165,000. This compares to net earnings of $191,000, or $0.07 per diluted share, on revenues of $3,187,000 in the fourth quarter of fiscal 2008.

Steve Springrose, Biotel President and CEO said, "While we are pleased with the results of operations for our fiscal year, CardioNet terminated its planned merger with Biotel in a subsequent event. Biotel has filed a complaint demanding that CardioNet complete the merger, and has asked for expedited treatment by the court. As a result of the terminated Merger Agreement, we expect revenues from a number of significant customers could be less in 2010 than in 2009."

                           3 months ended    3 months ended        %
                            June 30, 2009     June 30, 2008      Change
    Revenue                    $3,165,000        $3,187,000       -0.7%
    Net Income                   $174,000          $191,000       -8.9%
    Earnings Per Share,
     Basic                          $0.06             $0.07
    Earnings Per Share,
     Diluted                        $0.06             $0.07

                          12 months ended   12 months ended        %
                            June 30, 2009     June 30, 2008      Change
    Revenue                   $12,640,000       $11,495,000       10.0%
    Net Income                   $944,000          $666,000       41.7%
    Earnings Per Share,
     Basic                          $0.34             $0.25
    Earnings Per Share,
     Diluted                        $0.33             $0.23

SOURCE Biotel Inc.

SOURCE Biotel Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Biotel Announces Record Revenues and Earnings for Fiscal 2008
2. DOR BioPharma Announces Corporate Name Change to Soligenix and Begins Trading Under New Ticker Symbol SNGX
3. Amicus Therapeutics Announces Plan to Initiate Phase 1 Study of AT2220 for Pompe Disease
4. Sosei Announces Filing of NDA for SOH-075 (NorLevo(R)) in Japan
5. EPA announces research strategy to study nanomaterials
6. Oncolytics Biotech(R) Inc. Announces Reovirus and Cisplatin Research Supports U.S. Phase 2 Metastatic Melanoma Trial
7. MAQUET Cardiovascular Announces Leading Robotic Heart Surgeon Performs First Beating Heart Fully Endoscopic Bypass Surgery Using Miniaturized Cardiopulmonary Bypass System
8. Axial Biotech Announces Commercial Availability of SCOLISCORE(TM) AIS Prognostic Test
9. Alexandria Real Estate Equities, Inc. Announces Public Follow-on Offering of 3,000,000 Shares of Common Stock
10. Spherix Incorporated Announces Annual Shareholders Meeting Date
11. Compendia Bioscience Announces the Release of Oncomine 4 Research Edition
Post Your Comments:
(Date:10/12/2015)... NAMUR , Belgium , Oct. 12, ... today announced that full results from a completed clinical study ... pancreatic cancers have been published in the online issue of ... Epigenetics Society. The peer-reviewed study was conducted in collaboration with ... , and led by Roland Andersson , MD, PhD, ...
(Date:10/12/2015)... ... , ... LifeTrak , a leader in consumer fitness, heart rate and ... fitness tracker that seeks to meet the needs of multi-sport athletes. Zoom is the ... both in water and on land, making it the only fitness tracker an ...
(Date:10/10/2015)... Maryland , 10. Oktober, 2015 ... Matsui (Abgeordnete der Demokratischen Partei für Kalifornien) ihre ... bis 17. Oktober) in die Aufzeichnungen des Kongresses ... Plasma Protein Therapeutics Association (PPTA) und ihren ... , Hebung des Bewusstseins über Plasmaspenden weltweit ...
(Date:10/9/2015)... and ROCKVILLE, Md. , Oct. ... privately-held biotechnology company developing next generation vaccines based ... has entered into an exclusive worldwide licensing agreement ... the treatment or prevention of any and all ... agreement, Immunomic Therapeutics will receive an upfront payment ...
Breaking Biology Technology:
(Date:10/9/2015)... 09 2015 ... the "Samsung Galaxy S6 Fingerprint Sensor ... their offering. --> ) ... "Samsung Galaxy S6 Fingerprint Sensor - Reverse ... --> Research and Markets ( ...
(Date:10/7/2015)... 2015 NXTD ) ("NXT-ID" or ... growing mobile commerce market and creator of the Wocket® ... former long- term executive at American Express has been ... NXTD ) ("NXT-ID" or the "Company"), a biometric authentication ... creator of the Wocket® smart wallet announces Mr. ...
(Date:10/1/2015)... , Oct. 1, 2015  Biometrics includes ... analysing human body characteristics, such as fingerprints, eye ... purposes. Adoption of biometrics technology has been constantly ... the last five years. In addition to the ... is fingerprint recognition, other means of biometric authentication ...
Breaking Biology News(10 mins):